| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A potency test method for foot and mouth disease vaccine based on the serum neutralizing antibody response produced in cattle
|
Pay, T.W.F.
|
|
1992
|
10 |
10 |
p. 707-713
7 p.
|
article
|
| 2 |
Calendar
|
|
|
1992
|
10 |
10 |
p. 726-
1 p.
|
article
|
| 3 |
Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C
|
Costantino, Paolo
|
|
1992
|
10 |
10 |
p. 691-698
8 p.
|
article
|
| 4 |
DNA capable of site-specific integration into mycobacteria; phage L5 vector plasmid construction, Mycobacterium spp. and BCG transformation by site-specific integration; potential application to recombinant vaccine production
|
|
|
1992
|
10 |
10 |
p. 722-
1 p.
|
article
|
| 5 |
DNA sequence encoding bovine respiratory-syncytial virus G, F and N protein; used to produce recombinant protein and antibody; recombinant vaccine; diagnosis of virus infection
|
|
|
1992
|
10 |
10 |
p. 721-
1 p.
|
article
|
| 6 |
Equine herpes virus-4 thymidine-kinase-vaccine; expression in mammal host transformant; DNA sequence; potential monovalent, multivalent live recombinant vaccine vector
|
|
|
1992
|
10 |
10 |
p. 721-
1 p.
|
article
|
| 7 |
Foot and mouth disease vaccine potency test in cattle: the interrelationship of antigen dose, serum neutralizing antibody response and protection from challenge
|
Pay, T.W.F.
|
|
1992
|
10 |
10 |
p. 699-706
8 p.
|
article
|
| 8 |
Initial safety and immunogenicity studies of an oral recombinant adenohepatitis B vaccine
|
Tacket, Carol O.
|
|
1992
|
10 |
10 |
p. 673-676
4 p.
|
article
|
| 9 |
Major core proteins, p24s, of human, simian, and feline immunodeficiency viruses are partly expressed on the surface of the virus-infected cells
|
Nishino, Yoshii
|
|
1992
|
10 |
10 |
p. 677-683
7 p.
|
article
|
| 10 |
Multiple discontinuity as a remarkable feature of the development of acellular pertussis vaccines
|
Wardlaw, Alastair C.
|
|
1992
|
10 |
10 |
p. 643-651
9 p.
|
article
|
| 11 |
New antigenic conjugate of HIV virus major neutralization determinant; complex with Neisseria meningitidis outer membrane proteosome application in AIDS, AIDS-related complex therapy, recombinant vaccine
|
|
|
1992
|
10 |
10 |
p. 721-
1 p.
|
article
|
| 12 |
New antigenic polypeptide isolated from Neisseria meningitidis; useful as vaccine against meningitis and for N. meningitidis detection; DNA sequence; monoclonal antibody
|
|
|
1992
|
10 |
10 |
p. 722-
1 p.
|
article
|
| 13 |
New bacterial stress protein isolated from Corynebacterium; e.g. Corynebacterium jeikeium; mouse monoclonal antibody production; potential application in vaccine construction, and septicaemia and endocarditis diagnosis and therapy
|
|
|
1992
|
10 |
10 |
p. 722-
1 p.
|
article
|
| 14 |
New immunogenic peptide sequence from Echinococcus granulosus; useful in recombinant vaccine, diagnosis of hydatidosis; DNA sequence, vector, monoclonal antibody, hybridoma
|
|
|
1992
|
10 |
10 |
p. 721-722
2 p.
|
article
|
| 15 |
New rotavirus reassortants as vaccine components; containing human rotavirus VP4 and/or VP7 neutralization antigen gene and cattle rotavirus gene; isolation from infected CV-1, Vero, BSC-1, MA104, etc. cell culture
|
|
|
1992
|
10 |
10 |
p. 721-
1 p.
|
article
|
| 16 |
Parameters affecting the immunogenicity of microencapsulated tetanus toxoid
|
Esparza, Inmaculada
|
|
1992
|
10 |
10 |
p. 714-720
7 p.
|
article
|
| 17 |
Phase 1 clinical tests of influenza MDP-virosome vaccine (KD-5382)
|
Kaji, Masahide
|
|
1992
|
10 |
10 |
p. 663-667
5 p.
|
article
|
| 18 |
Production of porcine parvovirus empty capsids with high immunogenic activity
|
Martínez, Concepción
|
|
1992
|
10 |
10 |
p. 684-690
7 p.
|
article
|
| 19 |
Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis A
|
Ellerbeck, Edward F.
|
|
1992
|
10 |
10 |
p. 668-672
5 p.
|
article
|
| 20 |
Sequential intracoelomic and intrabursal immunization of chickens with inactivated Mycoplasma gallisepticum bacterin and iota carrageenan adjuvant
|
Elfaki, M.G.
|
|
1992
|
10 |
10 |
p. 655-662
8 p.
|
article
|
| 21 |
WHO—NIH meeting on host cell selection of influenza virus variants
|
Katz, Jacqueline M.
|
|
1992
|
10 |
10 |
p. 723-725
3 p.
|
article
|
| 22 |
Yellow fever 17DD vaccine virus is temperature sensitive when grown in mosquito C6-36 cells
|
Ledger, T.N.
|
|
1992
|
10 |
10 |
p. 652-654
3 p.
|
article
|
Journal description